PL BioScience and DewCell to jointly develop artificial human platelets for scalable cell culture media
"This collaboration is an important step on the way to replacing conventional products of animal origin"
PL BioScience GmbH, a German life science company specializing in the production and development of human platelet lysate (HPL) for cell expansion, announced the signing of a Letter of Intent (LOI) with Korean biotech company DewCell Biotherapeutics for the supply of artificial platelet raw material.
Under the terms of the agreement, DewCell will supply batches of artificial platelets for PL BioScience's artificial HPL solution, strengthening the company's ability to meet the growing global demand for high-quality, animal-free cell culture media.
"By combining DewCell's breakthrough human artificial platelet technology with PL BioScience's advanced manufacturing expertise, we aim to deliver high-performance synthetic, completely animal-free cell culture media that will set a new benchmark for the industry," said Jungsoo Park, Vice President of Marketing and Sales at PL BioScience. "This collaboration is an important step towards replacing traditional animal-derived products."
Global regulatory agencies - including the FDA (US Food and Drug Administration), EMA (European Medicines Agency), WHO (World Health Organization) and PMDA (Japanese Medicines and Medical Devices Agency) - are driving the transition to animal-free products in cell therapy and vaccine manufacturing. The declared aim is to improve product safety, ensure quality and take greater account of ethical aspects.
As a result, the use of platelet lysate, which contains high concentrations of growth factors from human platelets, is increasing and is attracting particular attention as an important ingredient for the production of cell-based drugs.
"This agreement demonstrates the industrial potential of artificial platelet technology," added Minwoo Lee, CEO of DewCell Biotherapeutics. "Our goal is to move beyond research applications and expand into GMP-compliant manufacturing and clinical applications."
DewCell produces artificial platelets using a system that differentiates stem cells into megakaryocytes and optimizes them for scalable platelet production.
This Letter of Intent follows the signing of a Memorandum of Understanding on March 27, which lays the foundation for a close collaboration to develop the world's first artificial platelet lysate to meet the growing global demand for animal-free cell culture media.
The signing ceremony was attended by Jungsoo Park (Vice President), Hatim Hemeda (CEO) and Christian Wilkes (CFO) of PL BioScience as well as Minwoo Lee (CEO) and Chihwa Kim (CTO) of DewCell.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of current news. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
Other news from the department business & finance
These products might interest you
CHOventure Growth Medium by Capricorn Scientific
High-Yield Protein Production with CHO Cells for Biopharmaceutical Applications
Optimized for High-Density Cultures and Enhanced Protein Yields in CHO Cell Bioprocessing
HEK Media by Sartorius
Serum-free cell culture media for HEK cells
Optimised for HEK293 cells and viral vector production, ISO 9001 certified
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Cell culture technology
Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.
Topic world Cell culture technology
Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.